CUF Shares CuFe Ltd
ASX · ASXLast in our picks 2026-10-05 — not in the current list; analysis below is from that screen
Small-cap biotech optionality exists, but investability remains constrained by thin liquidity.
Signal breakdown
- ▸Limited institutional sponsorship and low trading liquidity.
- ▾Below 50-day MA (-0.15%)
- ▸Above 200-day MA — long-term uptrend
Is CUF a buy right now?
Trend: CUF is trading above the 50-day average (+12.00%), RSI 46 — neutral momentum, with a 3-month return of +7.69%.
Valuation & quality: CuFe Ltd trades on price-to-book 3.73; fundamentals show net margin 0.0%, return on equity -23.6%.
Our screen: ACCUMULATE (score 1) — Small-cap biotech optionality exists, but investability remains constrained by thin liquidity.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -20.00% | +0.00% | +75.00% | -14.30% | -16.70% | +0.00% | +0.00% | +20.00% |
Fundamentals
Technical signals
About CuFe Ltd
CuFe Ltd operates as a mineral exploration and production company in Australia. It primarily explores for lithium, copper, iron ore, gold, niobium, and base metal deposits, as well as rare earth elements. The company was formerly known as Fe Limited and changed its name to CuFe Ltd in November 2021.
Sector: Basic Materials · Industry: Other Industrial Metals & Mining · Australia · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.